Helix-loop-helix proteins and lymphocyte development

Nature Immunology

Volumn 6, Issue 11, 2005, Pages 1079-1086

  Murre, Cornelis ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D3; HELIX LOOP HELIX PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; NOTCH RECEPTOR; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR ETS 1;

APOPTOSIS; BINDING AFFINITY; CELL CYCLE PHASE; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CELL TYPE; DENDRITIC CELL; DNA BINDING; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE SUBPOPULATION; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINEAGE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REARRANGEMENT, B-LYMPHOCYTE; HELIX-LOOP-HELIX MOTIFS; HOMEOSTASIS; HUMANS; IMMUNOGLOBULINS; MICE; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 27544442994     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1260     Document Type: Review

References (111)

1. Lazorchak, A., Jones, M.E. & Zhuang, Y. New insights into E-protein function in lymphocyte development. Trends Immunol. 26, 334-338 (2005).
2. Sun, X.H. Multitasking of helix-loop-helix proteins in lymphopoiesis. Adv. Immunol. 84, 43-77 (2004).
3. Bain, G., Gruenwald, S. & Murre, C. E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol. Cell. Biol. 13, 3522-3529 (1993).
4. Sloan, S.R., Shen, C.P., McCarrick-Walmsley, R. & Kadesch, T. Phosphorylation of E47 as a potential determinant of B-cell-specific activity. Mol. Cell. Biol. 16, 6900-6908 (1996).
5. Shen, C.P. & Kadesch, T. B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15, 4518-4524 (1995).
6. Sawada, S. & Littman, D.R. A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell. Biol. 13, 5620-5628 (1993).
7. Murre, C., McCaw, P.S. & Baltimore, D. A new DNA binding and dimerization motif in immunoglobulin-enhancer binding, daughterless, MyoD, and myc proteins. Cell 56, 777-783 (1989).
8. Aronheim, A., Shiran, R., Rosen, A. & Walker, M.D. The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc. Natl. Acad. Sci. USA 90, 8063-8067 (1993).
9. Quong, M.W., Massari, M.E., Zwart, R. & Murre, C. A new transcriptional-activation motif restricted to class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol. Cell. Biol. 13, 792-800 (1993).
10. Massari, M.E., Jennings, P.A. & Murre, C. The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells. Mol. Cell. Biol. 16, 121-129 (1996).
11. Sun, X.H. & Baltimore, D. An inhibitory domain of the E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64, 459-470 (1991).
12. Massari, M.E. & Murre, C. Helix-loop-helix proteins: Regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20, 429-440 (2000).
13. Corneliussen, B., Thornell, A., Hallberg, B. & Grundstrom, T. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J. Virol. 65, 6084-6093 (1991).
14. Rothenberg, E.V. (2002). T-lineage specification and commitment: A gene regulation perspective. Sem. Immunol. 14, 431-440 (2002).
15. Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L. & Weintraub, H. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59 (1990).
16. Norton, J.D. Id helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113, 3897-3905 (2000).
17. Yan, W. et al. High incidence of T-cell tumors in E2A-null mice and E2A/ Id1 double-knockout mice. Mol. Cell. Biol. 17, 7317-7327 (1997).
18. Rivera, R.R., Johns, C.P., Quan, J., Johnson, R.S. & Murre, C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 12, 17-26 (2000).
19. Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706 (1999).
20. Pan, L., Sato, S., Frederick, J.P., Sun, X.H. & Zhuang, Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 19, 5969-5980 (1999).
21. Ikawa, T., Kawamoto, H., Wright, L.Y.T. & Murre, C. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 3, 349-360 (2004).
22. Massari, M.E. et al. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell 4, 63-73 (1999).
23. Qiu, Y., Sharma, A. & Stein, R. p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol. Cell. Biol. 18, 2957-2964 (1998).
24. Bradney, C. et al. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J. Biol. Chem. 278, 2370-2376 (2002).
25. Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T. & Roeder, R.G. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 305, 1286-1289 (2004).
26. Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu. Rev. Immunol. 21, 759-806 (2003).
27. Allman, D. et al. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4, 168-174 (2003).
28. Schwartz, B.A. & Bhandoola, A. Circulating hematopoietic progenitors with T lineage potential. Nat. Immunol. 5, 953-960 (2004).
29. Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547-558 (1999).
30. Pui, J.C. et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11, 299-308 (1999).
31. Rothenberg, E.V. & Taghon, T. Molecular genetics of T cell development. Annu. Rev. Immunol. 23, 601-649 (2005).
32. Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885-892 (1994).
33. Zhuang, Y., Soriano, P. & Weintraub, H. The helix-loop-helix gene E2A is required for B cell formation. Cell 79, 875-884 (1994).
34. Sun, X.H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79, 893-900 (1994).
35. Heemskerk, M.H. et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix-loop-helix factor Id3. J. Exp. Med. 186, 1597-1602 (1997).
36. Bain, G. et al. E2A deficiency leads to abnormalities in T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17, 4782-4791 (1997).
37. Barndt, R.J., Dai, M. & Zhuang, Y. Functions of E2A/HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB. Mol. Cell. Biol. 20, 6677-6685 (2000).
38. + stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 192, 1775-1784 (2000).
39. Zhuang, Y., Jackson, A., Pan, L., Shen, K. & Dai, M. Regulation of E2A gene expression in B lymphocyte development. Mol. Immunol. 40, 1165-1170 (2004).
40. Shivdasani, R.A., Mayer, E.L. & Orkin, S.H. Absence of blood formation in mice lacking the T-cell leukemia protein tal-1/SCL. Nature 373, 432-443 (1995).
41. Ying, Q., Nichols, J., Chambers, I. & Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292 (2003).
42. Igarashi, H., Gregory, S., Yokota, T., Sakaguchi, N. & Kincade, P.W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17, 117-130 (2002).
43. Singh, H., Medina, K.L. & Pongubala, J.M.R. Contingent gene regulatory networks and B cell fate specification. Proc. Natl. Acad. Sci. USA 102, 4945-4953 (2005).
44. Busslinger, M. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22, 55-79 (2004).
45. Jaleco, A.C. et al. Genetic modification of human B cell development: B cell development is inhibited by the dominant-negative helix-loop-helix factor Id3. Blood 94, 2637-2646 (1999).
46. Bain, G. et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6, 145-154 (1997).
47. Zhuang, Y., Cheng, P. & Weintraub, H. B lymphocyte development is regulated by the combined dosage of three helix-loop-helix genes, E2A, E2-2 and HEB. Mol. Cell. Biol. 16, 2898-2905 (1996).
48. Hagman, J., Belanger, C., Travis, A., Turck, C.W. & Grosschedl, R. Cloning and characterization of early B-cell factor, a regulator of lymphocyte specific gene expression. Genes Dev. 5, 760-773 (1993).
49. Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263-267 (1995).
50. Urbanek, P., Wang, Z., Fetka, I., Wagner, E.F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901-912 (1994).
51. Hesslein, D.G. et al. Pax5 is required for recombination of transcribed, acetylated, 5′ IgH V gene segments. Genes Dev. 1, 37-42 (2003).
52. Seet, C.S., Brumbaugh, R.L. & Kee, B.L. Early B cell factor promotes B lymphopoesis with reduced interleukin 7 responsiveness in the absence of E2A. J. Exp. Med. 199, 1689-1700 (2004).
53. Kee, B.L. & Murre, C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J. Exp. Med. 188, 699-713 (1998).
54. O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21-31 (1999).
55. Nutt, S.L., Heavey, B., Rolink, A.G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401, 556-562 (1999).
56. Maier, H. et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immunol. 5, 1069-1077 (2004).
57. Quong, M.W. et al. Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. J. Exp. Med. 199, 1113-1120 (2004).
58. Greenbaum, S., Lazorchak, A.S. & Zhuang, Y. Differential functions for the transcription factor E2A in positive and negative regulation in pre-B lymphocytes. J. Biol. Chem. 279, 45028-45035 (2004).
59. Schebesta, M., Pfeffer, P.L. & Busslinger, M. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 17, 473-485 (2002).
60. Herblot, S., Aplan, P.D. & Hoang, T. Gradient of E2A activity in B cell development. Mol. Cell. Biol. 22, 886-900 (2002).
61. Hsu, L. et al. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19, 105-117 (2003).
62. Romanow, W.J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulun repertoire in nonlymphoid cells. Mol. Cell 5, 343-353 (2000).
63. k rearrangement. J. Exp. Med. 9, 1205-1211 (2004).
64. Goebel, P. et al. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and EBF in non lymphoid cells. J. Exp. Med. 194, 645-656 (2001).
65. Bain, G. Romanow, W.J., Albers, K. Havran, W.L. & Murre, C. Positive and negative regulation of V(D)J recombination by the E2A proteins. J. Exp. Med. 189, 289-300 (1999).
66. Bergman, Y. & Cedar, H. A stepwise epigenetic process control immunoglobulin allelic exclusion. Nat. Rev. Immunol. 4, 753-761 (2004).
67. Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J.V. J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1, 31-36 (2000).
68. Tanigaki, K. et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3, 443-450 (2002).
69. Quong, M.W., Harris, D.P., Swain, S.L. & Murre, C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18, 6307-6318 (1999).
70. Sayegh, C.E., Quong, M.E., Agata, Y. & Murre, C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4, 586-593 (2003).
71. Michael, N. et al. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19, 235-242 (2003).
72. Goldfarb, A.N., Flores, J.P. & Lewandowska, K. Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching. Mol. Immunol. 33, 947-956 (1996).
73. Roberts, V.J., Steenbergen, R. & Murre, C. Localization of E2A mRNA expression in developing and adult rat tissues. Proc. Natl. Acad. Sci. USA 90, 7583-7587 (1993).
74. Gonda, H. et al. The balance between Pax5 and Id2 activities is the key to AID expression. J. Exp. Med. 198, 1427-1437 (2003).
75. Ikawa, T., Fujimoto, S., Kawamoto, H., Katsura, Y. & Yokota, Y. Commitment to natural killer cells requires the helix-loop-helix protein, Id2. Proc. Natl. Acad. Sci. USA 98, 5164-5169 (2001).
76. Hacker, C. et al. Transcription profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4, 380-386 (2003).
77. Engel, I., Johns, C., Bain, G., Rivera, R.R. & Murre, C. Early thymocyte development is regulated by modulation of E2A protein activity. J. Exp. Med. 194, 733-745 (2001).
78. Herblot, S. et al. SCL and LM01 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expression. Nat. Immunol. 1, 138-144 (2000).
79. Schlissel, M., Voronova, A. & Baltimore, D. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev. 5, 1367-1376 (1991).
80. Engel, I. & Murre, C. E2A proteins enforce a proliferation checkpoint in developing thymocytes. EMBO J. 23, 202-211 (2004).
81. Bain, G., Quong, M.W., Soloff, R.S., Hedrick, S.M. & Murre, C. Thymocyte maturation is regulated by the activity of the helix-loop-helix protein, E47. J. Exp. Med. 190, 1605-1616 (1999).
82. Bain, G. et al. Regulation of the helix-loop-helix proteins, E2A and Id3. by the Ras-ERK MAPK cascade. Nat. Immunol. 2, 165-171 (2001).
83. Costello, P.S., Nicolas, R.H., Watanabe, Y., Rosewell, I. & Treisman, R. Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection. Nat. Immunol. 5, 289-298 (2004).
84. Bettini, M., Xi, H., Milbrandt, J. & Kersh, G.J. Thymocyte development in early growth response gene 1-deficient mice. J. Immunol. 169, 1713-1720 (2002).
85. Kee, B.L., Rivera, R.R. & Murre, C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat. Immunol. 2, 242-247 (2001).
86. Hollnagel, A., Oehlmann, V., Heymeyer, J., Ruther, U. & Nordheim, A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838-19845 (1999).
87. Frasca, D., Nguyen, D., Riley, R.L. & Blomberg, B.B. Decreased E12 and/or E47 transcription factor activity in the bone marrow as well as in the spleen of aged mice. J. Immunol. 170, 719-726 (2003).
88. Van der Put, E., Frasca, D., King, A.M., Blomberg, B.B. & Riley, R.L. Decreased E47 in senescent B cell precursors is stage-specific and regulated posttranslationally by protein turn-over. J. Immunol. 173, 818-827 (2004).
89. Li, H., Dai, M, & Zhuang, Y.A. T cell intrinsic role in a mouse model for primary Sjogren's syndrome. Immunity 21, 551-560 (2004).
90. Taghon, T.N., David, E., Zuniga-Pflucker, J.C. & Rothenberg, E.V. Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 19, 965-978 (2005).
91. Bailey, A.M. & Posakony, J.W. Suppressor hairless directly activates transcription of Enhancer of split complex genes in response to Notch receptor activity. Genes Dev. 9, 2609-2622 (1995).
92. Murre, C. et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58, 537-544 (1989).
93. Ordentlich, P. et al. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol. Cell. Biol. 18, 2230-2239 (1998).
94. Nie, L., Xu, M., Vladimirova, A. & Sun, X.H. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J. 22, 5780-5792 (2003).
95. Huang, Z., Nie, L., Xu, M. & Sun, X.H. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination. Mol. Cell. Biol. 24, 8951-8962 (2004).
96. Engel, I. & Murre, C. Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc. Natl. Acad. Sci. USA 96, 996-1001 (1999).
97. Kee, B.L., Bain, G. & Murre, C. II-7Rα and E47: Independent pathways required for development of multipotent lymphoid progenitors. EMBO J. 21, 103-113 (2002).
98. Kim, D., Peng, X.C. & Sun, X.H. Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice. Mol. Cell. Biol. 19, 8240-8253 (1999).
99. Zhao, F., Vilardi, A., Neely, R.J. & Choi, J.K. Promotion of cell cycle progression by basic helix-loop-helix E2A. Mol. Cell. Biol. 21, 6346-6357 (2001).
100. Peverali, F. et al. Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J. 13, 4291-4301 (1994).
101. Sicinska, E. et al. Requirements for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4, 451-456 (2003).
102. Morrow, M.A., Mayer, E.W., Perez, C.A., Adlam, M. & Siu, G. Overexpression of the helix-loop-helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36, 491-503 (1999).
103. Park, S.T., Nolan, G.P. & Sun, X.H. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells. J. Exp. Med. 189, 501-508 (1999).
104. Engel, I. & Murre, C. 1999. Transcription factors in hematopoiesis. Curr. Opin. Genet. Dev. 9, 575-579 (1999).
105. O'Neil, J., Shank, J., Cusson, N., Murre, C. & Kelliher, M. 2004. TAL1/SCL induces leukemia by inhibiting transcriptional activity of E47/HEB. Cancer Cell 5, 587-597 (2004).
106. Aspland, S.E., Bendall, H.H. & Murre, C. The role of E2A/Pbx-1 in leukemogenesis. Oncogene 20, 5708-5717 (2001).
107. Look, A.T. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastoid leukemia. Curr. Top. Microbiol. Immunol. 220, 45-53 (1997).
108. Asp, J., Thornemo, M., Inerot, S, & Lindahl, A. The helix-loop-helix transcription factors Id1 and Id3 have a functional role in control of cell division in human normal and neoplastic chondrocytes. FEBS Lett. 438, 85-90 (1998).
109. Nishimori, H. et al. The Id2 gene is a novel target of transcriptional activation by ES-ETS fusion proteins in Ewing family tumors. Oncogene 21, 8302-8309 (2002).
110. Rockman, S.P. et al. Id2 is a target of the β-catenin/T cell factor pathway in colon carcinoma. J. Biol. Chem. 276, 45113-45119 (2001).
111. Perk, J., Iavarone, A. & Benezra, R. Id family of helix-loolp-helix proteins in cancer. Nat. Rev. Cancer 5, 603-614 (2005).